摘要
目的:分析膀胱肿瘤患者膀胱灌注药物利用情况。方法:收集2002～2006年我院浅表性膀胱肿瘤患者住院及门诊重症病历资料186例,对膀胱灌注化疗药物使用情况进行分析。结果:全部浅表性膀胱肿瘤患者均使用化疗药物进行膀胱灌注预防肿瘤复发,共用抗肿瘤药物5种,其中部分患者使用免疫制剂联合用药;单药灌注复发率12.5%～52.0%,联合用药灌注复发率8.89%～16.67%。结论:化疗药物在浅表性膀胱肿瘤术后预防性膀胱灌注治疗中占主导地位。
Objective： To analyze the utilization of intravesical instillation drugs in bladder tumor patients. Method： 186 superficial bladder tumor patients were collected and their utilization of intravesical instillation drugs, analyzed. Result： All the patients received the intravesical instillation to prevent the recurrence of bladder tumor, and 5 anticancer drugs were used in them. Part of the patients received their combined immunotherapy. The recurrence rates were from 12.5% to 52.0% in the patients with single drug resection,and from 8.89% to 16.67% in the patients with combined medications. Conclusion： Chemotherapeutical drugs are the main part of intravesical instillation after transurethral resection of superficial bladder tumor.
出处
《药物流行病学杂志》
CAS
2009年第3期200-202,共3页
Chinese Journal of Pharmacoepidemiology
关键词
药物利用
膀胱肿瘤
膀胱灌注
Drug utilization
Bladder tumor
Intravesical instillation
